[Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010689:Phlebitis / Q000188:drug therapy*; D010998:Pleurisy / Q000188:drug therapy; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D013729:Terpenes / Q000009:adverse effects / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy; D014581:Urticaria / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013729:Terpenes
Esperienze clinico-terapeutiche con un nuovo preparato antiflogistico: DA 2370.